87 related articles for article (PubMed ID: 3758156)
1. Opposite effects of sulfated cholecystokinin on DA-sensitive adenylate cyclase in two areas of the rat nucleus accumbens.
Studler JM; Reibaud M; Herve D; Blanc G; Glowinski J; Tassin JP
Eur J Pharmacol; 1986 Jul; 126(1-2):125-8. PubMed ID: 3758156
[TBL] [Abstract][Full Text] [Related]
2. Sulfated cholecystokinin octapeptide (CCK8) failed to modulate basal or dopamine-stimulated adenylate cyclase activity in the rat striatum.
Morency MA; Ross GM; Kajiura JS; Mishra RK
Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(2-3):331-6. PubMed ID: 3387592
[TBL] [Abstract][Full Text] [Related]
3. Distinct properties of cholecystokinin-8 and mixed dopamine-cholecystokinin-8 neurons innervating the nucleus accumbens.
Studler JM; Reibaud M; Tramu G; Blanc G; Glowinski J; Tassin JP
Ann N Y Acad Sci; 1985; 448():306-14. PubMed ID: 3861123
[No Abstract] [Full Text] [Related]
4. Long-term effect of ovariectomy on dopamine-stimulated adenylate cyclase in rat striatum and nucleus accumbens.
Kumakura K; Hoffman M; Cocchi D; Trabucchi M; Spano PF; Müller EE
Psychopharmacology (Berl); 1979 Mar; 61(1):13-6. PubMed ID: 220653
[TBL] [Abstract][Full Text] [Related]
5. Interaction of ergot alkaloids with dopaminergic receptors in the rat striatum and nucleus accumbens.
Spano PF; Trabucchi M
Gerontology; 1978; 24 Suppl 1():106-14. PubMed ID: 618775
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological study on the mixed CCK8/DA meso-nucleus accumbens pathway: evidence for the existence of storage sites containing the two transmitters.
Studler JM; Reibaud M; Tramu G; Blanc G; Glowinski J; Tassin JP
Brain Res; 1984 Apr; 298(1):91-7. PubMed ID: 6326949
[TBL] [Abstract][Full Text] [Related]
7. Effect of morphine on dopamine-sensitive adenylate cyclase activity of nucleus accumbens.
Iwatsubo K
Jpn J Pharmacol; 1977 Dec; 27(6):903-5. PubMed ID: 609155
[No Abstract] [Full Text] [Related]
8. Involvement of adenylate cyclase inhibition in dopamine autoreceptor regulation of tyrosine hydroxylase in rat nucleus accumbens.
Onali P; Olianas MC
Neurosci Lett; 1989 Jul; 102(1):91-6. PubMed ID: 2571111
[TBL] [Abstract][Full Text] [Related]
9. Modification of the function of D1 and D2 dopamine receptors in striatum and nucleus accumbens of rats chronically treated with haloperidol.
Memo M; Pizzi M; Missale C; Carruba MO; Spano PF
Neuropharmacology; 1987 May; 26(5):477-80. PubMed ID: 2955241
[TBL] [Abstract][Full Text] [Related]
10. Non-DA prefronto-cortical efferents modulate D1 receptors in the nucleus accumbens.
Reibaud M; Blanc G; Studler JM; Glowinski J; Tassin JP
Brain Res; 1984 Jul; 305(1):43-50. PubMed ID: 6146386
[TBL] [Abstract][Full Text] [Related]
11. Topographical analysis of nucleus accumbens sites at which cholecystokinin potentiates dopamine-induced hyperlocomotion in the rat.
Crawley JN; Hommer DW; Skirboll LR
Brain Res; 1985 Jun; 335(2):337-41. PubMed ID: 4005562
[TBL] [Abstract][Full Text] [Related]
12. In vivo electrochemical analysis of cholecystokinin-induced inhibition of dopamine release in the nucleus accumbens.
Lane RF; Blaha CD; Phillips AG
Brain Res; 1986 Nov; 397(1):200-4. PubMed ID: 3801862
[TBL] [Abstract][Full Text] [Related]
13. Opioid receptors and inhibition of dopamine-sensitive adenylate cyclase in slices of rat brain regions receiving a dense dopaminergic input.
Heijna MH; Bakker JM; Hogenboom F; Mulder AH; Schoffelmeer AN
Eur J Pharmacol; 1992 Dec; 229(2-3):197-202. PubMed ID: 1337044
[TBL] [Abstract][Full Text] [Related]
14. Dopamine-sensitive adenylate cyclase in homogenates of rat nucleus accumbens: structure-activity studies and effects of agonists and antagonists.
Watling KJ; Woodruff GN; Poat JA
Eur J Pharmacol; 1979 Jun; 56(1-2):45-9. PubMed ID: 38129
[TBL] [Abstract][Full Text] [Related]
15. Relationship between D1 dopamine receptors, adenylate cyclase, and the electrophysiological responses of rat nucleus accumbens neurons.
Johansen PA; Hu XT; White FJ
J Neural Transm Gen Sect; 1991; 86(2):97-113. PubMed ID: 1683241
[TBL] [Abstract][Full Text] [Related]
16. Cholecystokinin-induced inhibition of dopamine neurotransmission: comparison with chronic haloperidol treatment.
Lane RF; Blaha CD; Phillips AG
Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(2-3):291-9. PubMed ID: 2819952
[TBL] [Abstract][Full Text] [Related]
17. Thyrotrophin releasing hormone stimulates release of [3H]-dopamine from slices of rat nucleus accumbens in vitro.
Kerwin RW; Pycock CJ
Br J Pharmacol; 1979 Nov; 67(3):323-5. PubMed ID: 115532
[TBL] [Abstract][Full Text] [Related]
18. Effect of lead exposure on dopaminergic receptors in rat striatum and nucleus accumbens.
Govoni S; Lucchi L; Missale C; Memo M; Spano PF; Trabucchi M
Brain Res; 1986 Aug; 381(1):138-42. PubMed ID: 3756492
[TBL] [Abstract][Full Text] [Related]
19. Coupling of dopamine D1 recognition sites with adenylate cyclase in nuclei accumbens and caudatus of schizophrenics.
Memo M; Kleinman JE; Hanbauer I
Science; 1983 Sep; 221(4617):1304-7. PubMed ID: 6310753
[TBL] [Abstract][Full Text] [Related]
20. Reversal by cholecystokinin of apomorphine-induced inhibition of dopamine release in the nucleus accumbens of the rat.
Blaha CD; Phillips AG; Lane RF
Regul Pept; 1987 Jun; 17(6):301-10. PubMed ID: 3602473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
